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2Co-first

SUMMARY

It is becoming increasingly clear that transcription
factors operate in complex networks through
thousands of genomic binding sites, many of which
bind several transcription factors. However, the
extent and mechanisms of crosstalk between transcription factors at these hotspots remain unclear.
Using a combination of advanced proteomics and
genomics approaches, we identify 12,000 transcription factor hotspots (400 bp) in the early phase
of adipogenesis, and we find evidence of both simultaneous and sequential binding of transcription factors at these regions. We demonstrate that hotspots
are highly enriched in large super-enhancer regions
(several kilobases), which drive the early adipogenic
reprogramming of gene expression. Our results indicate that cooperativity between transcription factors
at the level of hotspots as well as super-enhancers is
very important for enhancer activity and transcriptional reprogramming. Thus, hotspots and superenhancers constitute important regulatory hubs
that serve to integrate external stimuli on chromatin.
INTRODUCTION
A number of genome-wide studies on transcription factor
binding in multiple different cell systems have shown that
many transcription factors tend to colocalize with other factors
on chromatin (Biddie et al., 2011; Grøntved et al., 2013; Heinz
et al., 2010; Hurtado et al., 2011; Lefterova et al., 2008; Nielsen
et al., 2008), and transcription factor hotspots occupied by multiple factors have even been described in some cell types (Boergesen et al., 2012; Chen et al., 2008; Gerstein et al., 2012; He
et al., 2011; Moorman et al., 2006; Siersbæk et al., 2011). However, the functional significance of this colocalization is currently
unclear. In addition, Whyte et al. (2013) and Lovén et al. (2013)
recently demonstrated the existence of super-enhancers, which
are large genomic regions (several kilobases) containing clusters
of closely spaced transcription factor binding regions. These
large super-enhancers are characterized by very high levels of
Mediator subunit 1 (MED1) binding and seem to regulate cell

identity. The relation between hotspots and super-enhancers is
currently unclear.
Adipocyte differentiation is a well-studied differentiation
process, and many of the transcription factors acting in a
sequential manner to activate this differentiation process have
been described (Farmer, 2006; Lefterova and Lazar, 2009;
Rosen and MacDougald, 2006; Siersbæk et al., 2012b). 3T3-L1
preadipocytes differentiate into mature adipocytes in a rather
synchronous and efficient manner upon exposure to a cocktail
of adipogenic inducers, and we previously demonstrated that
this is associated with extensive reprogramming of the chromatin landscape within the first 4 hr of differentiation, as evidenced by the dynamic change in DNase I hypersensitive
(DHS) site profiles (Siersbæk et al., 2011). This cell line therefore
represents an ideal model system for studying transcription factor cooperativity on chromatin during reprogramming of the
genome.
Here, we combined advanced genomics and proteomics
techniques to obtain molecular insight into the interplay among
transcription factors that drive the early adipogenic reprogramming of 3T3-L1 cells. We demonstrate extensive colocalization
of transcription factors in hotspots and super-enhancers, and
show that hotspots are highly enriched in super-enhancer
regions. Furthermore, our work reveals extensive cooperativity
between transcription factors at the level of hotspots as well
as super-enhancers, and indicates that this cooperativity
is very important for transcriptional reprogramming during
differentiation.
RESULTS
A Combined Genomics and Proteomics Approach
Identifies Key Members of the Early Adipogenic
Transcription Factor Network
Based on chromatin immunoprecipitation sequencing (ChIPseq) profiling, we previously reported 1,000 transcription factor
hotspots occupied by five transcription factors during early 3T3L1 adipogenesis (Siersbæk et al., 2011). Here, to further investigate the extent of hotspot formation and characterize their
composition, we undertook a combined genomics and proteomics approach (Figure 1). First, we performed coimmunoprecipitation (coIP) of C/EBPb-associated proteins 4 hr following
induction of 3T3-L1 differentiation (Figure S1A), i.e., the time
point at which we previously demonstrated dramatic chromatin
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Figure 1. Schematic Overview of the Combined Genomics and
Proteomics Approach Used to Identify Key Early Regulators of
Adipocyte Differentiation
Motif analyses of DNA sequences at DHS sites 4 hr after induction of differentiation of 3T3-L1 cells obtained from previous analyses (Siersbæk et al.,
2011) were combined with proteomics analyses of C/EBPb-associated proteins to confidently identify candidate transcription factors involved in early
adipogenic reprogramming.

remodeling (Siersbæk et al., 2011). C/EBPb was chosen as the
bait for the proteomics analyses, because it has been shown
to play an important role in regulating the early phase of adipocyte differentiation both in vitro and in vivo (Tanaka et al.,
1997; Tang et al., 2003; Zhang et al., 2004), and it colocalizes
extensively with the few factors we previously profiled by
ChIP-seq (Siersbæk et al., 2011). The protein mixture was
analyzed by liquid chromatography-tandem mass spectrometry
(LC-MS/MS; Figure 1, left).
We identified 292 proteins that coprecipitate with C/EBPb in
two independent biological replicates (Figure S1B; Tables S1
and S2). Gene Ontology (GO) annotation revealed that many of
the identified proteins are transcriptional regulators, but we
also identified proteins involved in RNA splicing and processing,
as well as kinases, helicases, and ribosomal proteins (Figure 2A).
The group of transcriptional regulators includes many coregulators and transcription factors (Figure 2B), some of which have
previously been shown to associate with C/EBPb, such as its
heterodimerization partner C/EBPd, as well as Krüppel-like factor 5 (KLF5) (Oishi et al., 2011), transcriptional intermediary factor
1b (TIF-1b) (Chang et al., 1998), and p300 (Mink et al., 1997).
Most of these are highly enriched (>10-fold) in the C/EBPb
immunoprecipitation compared with the nonspecific immunoglobulin G (IgG) control, indicating a strong and specific association with C/EBPb. Several of the transcription factors identified
as C/EBPb-interacting proteins by proteomics analysis have
also been shown to regulate the early phase of adipocyte differentiation, e.g., KLF4 (Birsoy et al., 2008), KLF5 (Oishi et al., 2011),
GR (Siersbæk et al., 2011; Steger et al., 2010), and PBX1 (Monteiro et al., 2011), clearly indicating that our approach is a powerful strategy for identifying biologically meaningful regulators of
the differentiation process.
A comparison of the identified proteins with our previously
published de novo motif analysis of DNA sequences at DHS
regions identified at the 4 hr time point (Siersbæk et al., 2011;
1444 Cell Reports 7, 1443–1455, June 12, 2014 ª2014 The Authors

Figure S1A, right) revealed binding motifs for many of the transcription factors identified as C/EBPb-associated proteins (Figure 2C). This indicates that these proteins bind directly to DNA
at many open chromatin regions during early adipogenesis.
Importantly, a major benefit of this combined approach is that
it allows us to distinguish among different transcription factors
that bind to the same motif, which is almost impossible based
on sequence analyses alone. For example, we identify JunB
and FOSL2 from the large AP1 family, and KLF4, KLF5, and
SP1 from the large KLF/SP1 family as possible candidates
for binding the AP1 and KLF/SP1 motif in DHS sites, respectively. Taken together, these results demonstrate the power of
combining proteomics analyses of proteins associated with
known key regulators with motif analyses of accessible chromatin regions in the genome to identify novel transcriptional regulators of biological processes.
Extensive Colocalization of Transcription Factors at
Hotspot Regions
We chose to perform ChIP-seq profiling of eight factors from the
combined proteomics and genomics screen described above
(i.e., KLF4, KLF5, JunB, Fos-like antigen 2 [FOSL2], signal transducer and activator of transcription 1 (STAT1), activating transcription factor 2 [ATF2], ATF7, and PBX1 [indicated by asterisks
in Figure 2B]) based on availability of high-quality antibodies. In
addition, we chose to profile vitamin D receptor (VDR) (Blumberg
et al., 2006; Cianferotti and Demay, 2007) and c-Jun (Mariani
et al., 2007; Wang and Scott, 1994), which have previously
been implicated in early stages of adipocyte differentiation.
When combined with our previously published profiles of
C/EBPb, C/EBPd, GR, and STAT5A (Siersbæk et al., 2011) as
well as a new version of our previously published RXR profile,
the results reveal a total of 54,724 transcription factor binding regions (250–400 bp), most (58%) of which are occupied by more
than one factor. Importantly, all of the investigated transcription
factors colocalize with C/EBPb on chromatin (see Figures 3B,
3C, and S2A), demonstrating a high degree of concordance between these genomics data and the proteomics analyses. Quantification of transcription factor colocalization shows that for all
factors, most binding sites are occupied by additional factors,
although the extent of colocalization with other factors seems
to be factor dependent (Figure 3A). Importantly, the observed
degree of transcription factor colocalization is much higher
than that found for random sites (i.e., only 1.5% of randomized
binding sites are occupied by more than one factor; Figure 3A,
bottom). Based on this large number of investigated factors,
we could identify 12,000 hotspot regions that are occupied
by at least five transcription factors, demonstrating that extensive colocalization of transcription factors is a common phenomenon. In fact, 40%–82% of the binding sites for a given factor are
located in hotspots based on these data sets (Figure 3A), which
is likely to be an underestimate, since we only analyzed a subset
of the transcription factors that are active during this differentiation process. From the nine largest groups of hotspots, it is
evident that many different types of hotspots are occupied by
distinct subsets of factors (Figure 3B; the degree of co-occurrence of all transcription factor pairs at hotspots is illustrated in
Figure S2A). Thus, it is unlikely that hotspots are the result of
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unspecific associations between factors and accessible chromatin regions; instead, they are likely to be formed by the specific association of multiple factors with the same genomic regions. Interestingly, we identify 138 regions that are specifically
targeted by all of the 15 investigated factors (Figure 3B). Given
the importance of peroxisome proliferator-activated receptor g
(PPARg) for adipocyte differentiation, it is highly interesting to
note that two such major hotspots are located in close proximity
to the Pparg2 TSS (Figure 3C).
Given the high number of transcription factors that associate
with hotspots, we performed re-ChIP experiments to assess
whether transcription factors bind simultaneously or sequentially
to hotspot regions (Figures 3D and S2B–S2E). For the sites
investigated, we could demonstrate that five of the seven tested
pairs of factors (i.e., JunB-C/EBPb, KLF4-C/EBPb, ATF2-JunB,
ATF7-JunB, and KLF5-C/EBPb) seem to occupy chromatin at
these hotspots simultaneously, at least within the time resolution
of the ChIP methodology. In contrast to these pairs, JunB and
KLF4 show robust binding to the investigated regions in single
ChIP experiments (Figure S2D), but they do not seem to occupy
these regions at the same time, despite the fact that these
factors are known to recognize completely different motifs (Figure 3D). The same is true for KLF4 and KLF5 (Figure S2C), which
is expected because they bind to the same motif. Thus, in these
data sets we find evidence for both simultaneous binding and
dynamic sequential association of transcription factors with
hotspots.
Hotspots Are Key Enhancer Regions
Analysis of the location of the identified transcription factor
binding sites relative to genes revealed that even though all types
of binding sites, in particular those occupied by few of the investigated factors, are enriched in gene promoters compared with a
random control, most binding sites are found distal to transcription start sites, and this trend becomes more pronounced the
more factors are bound to these regions (Figure 4A). Thus, hotspots are primarily found at gene distal regions. Interestingly,
genome-wide profiling of the histone marks H3K4me1,
H3K4me2, and H3K27ac, which were previously shown to
characterize enhancers (Creyghton et al., 2010; Lupien et al.,
2008; Rada-Iglesias et al., 2011), demonstrated that both distal
non-hotspots (i.e., regions occupied by one to four factors)
and hotspots (R5 factors) are enriched for these three marks
(Figure 4B). However, hotspots are associated with significantly
higher levels of all marks than non-hotspot regions, demonstrating that many of the identified distal binding regions, and
distal hotspots in particular, have the epigenomic profile of active
enhancers.

Interestingly, genome-wide profiling of the coactivators
Mediator subunit 1 (MED1), the histone acetyltransferase p300,
and the SWI/SNF chromatin remodeling factor Brahma-related
gene 1 (BRG1), reveals that the more factors that colocalize to
a given region, the higher are the levels of coactivator recruitment (Figure 4C). Consistent with the increased BRG1 recruitment, the DHS-seq signal (Siersbæk et al., 2014, this issue of
Cell Reports) also increases with the number of factors (Figure S3A). Importantly, the input control does not show a similar
increase in signal compared with the coactivator ChIPs (Figure S3B). Taken together, these results indicate that transcription factors cooperate extensively at hotspots to remodel the
chromatin, recruit coregulators associated with enhancer function, and establish an epigenomic enhancer profile.
To correlate the different types of transcription factor
binding regions with transcriptional changes during the first
4 hr of differentiation, we employed 4-thiouridine (4sU)-RNAseq, which is a robust and reproducible method that primarily
maps newly synthesized RNA (Rabani et al., 2011; Figure S3C).
Using this method, we identify 2,374 and 2,022 genes that are
induced and repressed, respectively, during the first 4 hr of differentiation (Figure 4D). We furthermore define a group of 549
genes that are constitutively expressed (%2.5% change in
expression). Interestingly, hotspots, and in particular those
occupied by all 15 factors, are highly enriched near induced
genes compared with regions occupied by fewer factors (Figures
4E, S3D, and S3E). Although we cannot exclude the possibility
that hotspots also play a role in transcriptional repression, these
analyses strongly suggest that hotspots are key regulatory regions involved in activating the gene program associated with
early adipocyte differentiation.
Hotspots Are Central Constituents in Super-Enhancers
Whyte et al. (2013) and Lovén et al. (2013) recently reported the
existence of super-enhancers, which are large regulatory
regions in the genome that have a high density of transcription
factor binding sites and very high levels of MED1. To identify
super-enhancers 4 hr after induction of differentiation of 3T3L1 cells, we merged transcription factor binding sites in close
proximity and defined super-enhancers and regular transcription
factor binding regions based on the level of MED1 as shown in
Figure 5A. Using this approach, we identified 340 superenhancers that have ultrahigh levels of MED1 binding (Figure 5A)
as well as p300 recruitment (Figure S4A). Because superenhancers are composed of multiple constituent binding sites
that were merged together in this analysis, they are much larger
(median size of 33,740 bp) than regular transcription factor
binding regions (Figure S4B). Importantly, we show that

Figure 2. Combined Genomics and Proteomics Approach Reveals Candidate Regulators of Early Adipocyte Differentiation of 3T3-L1 Cells
(A) Main GO categories from the STRING database (Szklarczyk et al., 2011) associated with the C/EBPb-interacting proteins identified by MS analysis of C/EBPb
immunoprecipitates on nuclear extract from 3T3-L1 cells induced to differentiate for 4 hr. All proteins were identified in two independent experiments, except for
the transcription factors FOSL2, GR, STAT1, and PBX1, which were only identified in one of the replicates.
(B) All of the transcriptional regulators identified in (A) were subdivided into more specific GO categories, and the fold enrichment in the C/EBPb IP relative to the
control IP using a nonspecific IgG antibody is shown. Transcription factors that we subsequently subjected to genomics analyses using ChIP-seq are indicated by
an asterisk.
(C) Summary of the results from motif analyses of DHS sites 4 hr after induction of differentiation (Siersbæk et al., 2011). Motifs were identified by MEME analysis
(Bailey et al., 2009). The transcription factors identified in the C/EBPb coIP that have been shown to bind to these motifs are indicated.
See also Figure S1 and Tables S1 and S2.
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constituent binding regions within super-enhancers have higher
levels of MED1 and transcription factor binding than regular transcription factor binding regions outside super-enhancers (Figures 5B and S4D). This suggests that constituents within super-enhancers cooperate to establish a large enhancer region
comprised of multiple particularly strong enhancers. Taken
together, these findings show that the extremely high levels of
MED1 recruitment to super-enhancers reflect the facts that (1)
super-enhancers are comprised of multiple individual binding
regions, and (2) constituent binding regions in super-enhancers
have on average much higher levels of MED1 recruitment
compared with regular transcription factor binding regions, presumably at least in part as a consequence of high levels of transcription factor binding.
It is interesting to note that early hotspots both within and
outside super-enhancers are enriched for PPARg binding in
mature adipocytes (Haakonsson et al., 2013; Figure S4C), indicating that a subset of early established hotspots may remain
active enhancers also in mature adipocytes and be involved in
regulating the mature adipocyte gene program. This is consistent with our previous finding that many chromatin regions that
become accessible within the first 4 hr of differentiation remain
open throughout the differentiation process (Siersbæk et al.,
2011).
Interestingly, early super-enhancers are highly enriched near
early-induced genes and depleted near early-repressed genes,
whereas regular transcription factor binding regions (which
also include hotspots) outside super-enhancers are not enriched
near regulated genes (Figure 5C). Similarly, we identified superenhancer-associated genes by assigning each region to the
nearest gene. Consistent with the findings above, the superenhancer-associated genes are induced during the first 4 hr of
differentiation, whereas genes associated with regular transcription factor binding regions in general show no change in mRNA
levels (Figure S4E). Super-enhancer-associated genes are enriched in GO terms linked to the early phase of the differentiation
process, including extracellular matrix-receptor interactions, cell
proliferation, and growth factor binding (Figure S4F). Thus,
super-enhancers appear to be central drivers of the early transcriptional reprogramming that defines this phase of the differentiation process (examples of super-enhancer-associated genes
are shown in Figure 5E). Intriguingly, transcription factor binding
regions occupied by multiple transcription factors, in particular
hotspots occupied by all 15 investigated factors, are highly en-

riched in super-enhancer regions compared with binding sites
occupied by fewer factors (Figure 5D). In fact, practically all
super-enhancers (99%) contain at least one hotspot. Taken
together, these results suggest that hotspots are central constituents in super-enhancer regions that control the gene program
that drives the early phase of the adipocyte differentiation
process.
Effect of Transcription Factor Perturbation on Hotspot
and Super-Enhancer Activity
To obtain functional insight into transcription factor cooperativity
in the formation of hotspots and super-enhancers, we perturbed
transcription factor activity using two different approaches and
analyzed MED1 recruitment using ChIP-seq (Figure 6, left). First,
we induced cells to differentiate for 4 hr using the normal adipogenic cocktail (i.e., fetal bovine serum, insulin, a cAMP-elevating
agent, and dexamethasone) or the adipogenic cocktail without
the strong GR agonist, dexamethasone. Second, we performed
short hairpin RNA (shRNA)-mediated knockdown of C/EBPb
(Figure S4G) prior to induction of differentiation using the normal
adipogenic cocktail.
Interestingly, omission of dexamethasone from the adipogenic cocktail had a significantly greater effect on MED1
recruitment to GR binding sites within super-enhancers
compared with GR binding sites outside super-enhancers
(Figure 6A, middle), suggesting that cooperation between constituents in super-enhancers is particularly sensitive to perturbation of GR. Consistent with the notion that constituents
within super-enhancers cooperate to recruit coactivators,
MED1 recruitment to constituent binding regions without GR
in super-enhancers is also significantly more affected by omission of dexamethasone than is MED1 recruitment to binding
sites outside super-enhancers. Remarkably, the effect of dexamethasone omission on MED1 binding is significantly less
for hotspots, whether located in super-enhancers or not,
compared with binding regions occupied by few factors (Figure 6A, right). Thus, hotspots are much less sensitive to GR
perturbation than non-hotspots, which indicates that transcription factor cooperation at the level of hotspots can compensate
for the loss of GR.
In contrast to these findings, knockdown of the general
transcription factor C/EBPb affects C/EBPb binding sites within
and outside super-enhancers to the same extent (Figure 6B,
middle). Furthermore, the effect of C/EBPb knockdown on

Figure 3. Transcription Factors in the Early Adipogenic Network Colocalize at Transcription Factor Hotspots
(A) For each factor, the number of binding sites that are occupied by one (only the factor itself) to 15 factors is shown along with the percentage of binding sites that
are located in hotspot regions. The numbers of all transcription factor binding sites based on the ChIP-seq data sets and all binding sites redistributed randomly in
the genome that are occupied by one to 15 factors are shown at the bottom.
(B) Heatmap of transcription factor binding in a 2 kb region around the center of the nine largest groups of hotspots. Input signal (Siersbæk et al., 2011) is shown as
a control.
(C) Screen shot from the UCSC genome browser (http://genome.ucsc.edu; Kent et al., 2002) showing the binding profiles of 15 transcription factors as well as
DHS-seq data (Siersbæk et al., 2014) and input control (Siersbæk et al., 2011) at the Pparg2 locus 4 hr after induction of differentiation. The two arrows point to
two hotspots occupied by all 15 investigated factors.
(D) Re-ChIP results for four different transcription factor pairs at three hotspots as well as control sites. Hotspots 1–3 refer to regions in the Pparg2 promoter,
downstream of BC026439, and in an Xrcc4 intron, respectively (see Figure S2D). The negative control is not occupied by any of the investigated factors, whereas
the control sites to the right in each subfigure are only occupied by one of the two factors investigated (screen shots for these regions are shown in Figure S2E).
Results are representative of two independent experiments.
See also Figure S2.
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Figure 4. Extensive Transcription Factor Cooperativity at the Level of Hotspots
(A) Location of transcription factor binding sites occupied by one to 15 factors relative to the transcription start site (TSS) of RefSeq genes. The location of
randomly placed binding sites of the same size is shown as a reference.
(B) The level of three histone marks characteristic of enhancers regions (i.e., H3K4me1, H3K4me2, and H3K27ac) in the vicinity of distal (>2 kb away from the TSS)
non-hotspots (occupied by one to four factors) and hotspots (occupied by R5 factors). Input (Siersbæk et al., 2011) is shown as a control.
(C) Number of sequence tags at the regions defined in (A) for the Mediator subunit MED1, the histone acetyltransferase p300, and the SWI/SNF chromatin
remodeling factor BRG1.
(D) Scatterplot showing the number of exon reads per kilobase (RPK) for all expressed genes (13,019). Significantly (p % 0.01) induced genes are green (2,374)
and repressed genes are red (2,022). A group of constitutive genes (blue, 549 genes) was defined as those having %2.5% change in expression, and the rest of
the nonregulated genes are colored gray.
(E) Enrichment of different types of binding sites (i.e., those occupied by one, two, three, or four factors, or at least five factors) near the top 500 most induced and
repressed genes, respectively. Enrichment was determined as the number of binding sites per gene within different distances from the TSS (10–100 kb) of
regulated genes relative to the number of binding sites per gene of constitutive genes as defined in (D).
See also Figure S3.
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Figure 5. Hotspots Are Enriched in Early Adipogenic Super-Enhancers
(A) All the identified transcription factor binding sites (54,724) that were within 12.5 kb of each other were merged, resulting in 25,632 regions. These regions were
ranked by their MED1 signal, where the input background (Siersbæk et al., 2011) had been subtracted. Regions with a MED1 signal (minus background) above
700 reads per 10 M total reads were defined as super-enhancers. All other regions were denoted as regular transcription factor binding regions.
(B) Number of MED1 sequence tags in constituents (250 bp window) in normal transcription factor binding regions and super-enhancers occupied by one to 15 factors.
(C) Enrichment of super-enhancers and regular transcription factor binding sites in the vicinity of the top 500 most regulated genes. Enrichment was determined
as in Figure 4E.
(D) Fraction of transcription factor binding sites occupied by one to 15 factors that are found in super-enhancer regions. The significance of the higher occurrence
of hotspots (i.e., binding sites occupied by at least five factors) relative to non-hotspots (i.e., binding sites occupied by one to four factors) within super-enhancer
regions as determined by Fisher’s exact test is shown at the top.
(E) Screen shot from the UCSC genome browser (http://genome.ucsc.edu; Kent et al., 2002) showing six super-enhancers in the vicinity of several genes,
including Il1r1 and Il1rl1, which are highly induced.
See also Figure S4.
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Figure 6. Transcription Factors Differ in their Relative Importance for Super- and Regular-Enhancer Activity
(A and B) Schematic illustration of the experimental setup (left). The mean loss of MED1 recruitment to constituents in regular transcription factor binding regions
and super-enhancers upon omission of dexamethasone from the adipogenic cocktail or shRNA-mediated C/EBPb knockdown is shown in the middle. Error bars
illustrate the 95% confidence interval around the mean. To the right is shown the median fraction of MED1 recruitment retained upon omission of dexamethasone
or knockdown of C/EBPb, as described above at regions occupied by one to 15 factors within or outside super-enhancers. The transparent ribbon shows the
95% confidence interval around the median as determined by bootstrapping (Canty and Ripley, 2013; Davison and Hinkley, 1997). *p < 0.05, Student’s t test.
See also Figure S4.

MED1 recruitment is not influenced by the number of transcription factors recruited (Figure 6B, right). Taken together, these results indicate that although loss of GR can be compensated for
by transcription factor cooperativity at the level of hotspots,
the same is not the case for C/EBPb, which is equally important
for MED1 recruitment irrespectively of how many other factors
are associated with a binding region. Furthermore, the results
indicate that transcription factors differ in their relative importance for the activity of super-enhancers and regular transcription factor binding regions.
DISCUSSION
Here, we describe the relationship between super-enhancers
and hotspots and take major steps toward understanding the
complexity of both types of chromatin regions during genomic
reprogramming associated with early adipogenesis. Motif
analysis of DNA sequences at specific chromatin regions (e.g.,

DNase I hypersensitive sites or regions enriched for specific histone marks) is a commonly used strategy for identifying new
candidate transcription factors involved in regulating a particular
transcriptional response (Carroll et al., 2005; Heinz et al., 2010;
Mikkelsen et al., 2010; Siersbæk et al., 2011; Steger et al.,
2010). In general, however, motif searches have low specificity
(Wasserman and Sandelin, 2004), and in addition, related transcription factors bind to very similar motifs (Sandelin and Wasserman, 2004), which makes it challenging to identify cognate
transcription factors from a motif search alone. Here, we demonstrate that the combination of proteomics-based identification of
proteins associated with a known key regulator of adipocyte differentiation (i.e., C/EBPb) and motif analyses of accessible chromatin regions is a very powerful approach for identifying a large
repertoire of factors in the complex transcription factor network
that controls early adipocyte differentiation. This approach is
likely to be widely applicable for investigating the transcription
factor networks that control other biological processes.
Cell Reports 7, 1443–1455, June 12, 2014 ª2014 The Authors 1451

C/EBPs

AP1

KLFs

NRs
STATs
PBX1

ATFs

Hotspot
~400 bp
Non-hotspots
Hotspots

MED1

Super-enhancer
Figure 7. Model of Transcription Factor Cooperativity in Adipogenic
Hotspots and Super-Enhancers
Multiple diverse transcription factors colocalize at small genomic regions
termed transcription factor hotspots (400 bp), which are central constituents
in large super-enhancers (10–80 kb). Super-enhancers are characterized by
very high levels of MED1 recruitment, and several lines of evidence suggest
that constituents within super-enhancers cooperate to recruit MED1. Ultimately, establishment of super-enhancer regions results in activation of
nearby genes characteristic of the early phase of adipogenesis.

One of the key findings from our study is that transcription
factors, through the formation of hotspots, cooperate in recruitment of coactivators, chromatin remodeling, and establishment
of an active epigenomic signature, as well as the activation of
nearby genes during early adipogenesis. Thus, we suggest that
crosstalk between transcription factors in hotspots is important
for developmental reprogramming of the genome. Based on
sequential ChIP experiments, we demonstrate that several
transcription factor pairs associate simultaneously with hotspot
regions, but, interestingly, we also find evidence of sequential
and mutually exclusive binding of transcription factors to hotspots, indicating a dynamic exchange of factors at these sites.
This is consistent with previous findings demonstrating transient
interactions between transcription factors and chromatin
(McNally et al., 2000; Métivier et al., 2003; Shang et al., 2000;
Voss et al., 2011).
Importantly, our data indicate that cooperativity between
transcription factors extends beyond hotspots to also include
cooperativity between the constituent binding sites of super-enhancers (Figure 7), i.e., the large clusters of transcription factor
binding regions that were recently reported to be central drivers
of gene programs that define cell identity (Lovén et al., 2013;
Whyte et al., 2013). We identify 340 super-enhancer regions
that appear to be central drivers of the gene programs that are
activated acutely (i.e., within 4 hr) by the adipogenic cocktail,
and we show that hotspots are highly enriched in these superenhancers (Figure 7). Our finding of higher levels of MED1 binding in super-enhancer constituents compared with regular transcription factor binding regions indicates that in addition to
transcription factor cooperativity on a small genomic scale in
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hotspots, individual enhancers within super-enhancer regions
also appear to cooperate to recruit coactivators, presumably
through chromatin looping (Figure 7). Consistent with this, we
find that perturbation of GR binding by omission of dexamethasone affects MED1 recruitment not only to super-enhancer constituents that bind GR but also to their neighboring constituents
that do not bind GR.
Our finding that GR constituents in super-enhancers are more
sensitive to perturbation of GR than GR-binding regions outside
super-enhancers is consistent with the recent finding that superenhancers are particularly sensitive to drug treatment in cancer
cells (Lovén et al., 2013). This indicates that these adipogenic
super-enhancers may present new drug targets for controlling
adipocyte differentiation, which is of high clinical relevance.
Interestingly and in contrast to what was found for GR, perturbation of C/EBPb affects the activity of super-enhancers and
regular binding regions to the same extent, demonstrating that
transcription factors differ in their relative importance for the
activity of super-enhancers and regular enhancers. This is
consistent with a more general role of C/EBPb in enhancer
establishment.
In conclusion, we demonstrate extensive colocalization of
transcription factors in hotspots that are important components
of super-enhancers. Importantly, we show that transcription
factor cooperativity plays a key role in defining enhancer activity
at the level of hotspots as well as super-enhancers. These results
indicate that hotspots and super-enhancers function as central
hubs that serve to integrate external signals through transcription factor colocalization on chromatin.
EXPERIMENTAL PROCEDURES
Cell Culture
3T3-L1 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% calf serum. Cells were induced to differentiate in
DMEM supplemented with 10% fetal bovine serum, 1 mM dexamethasone,
0.5 mM 3-isobutyl-1-methylxanthine, and 1 mg/ml insulin essentially as
described previously (Helledie et al., 2002).
shRNA-Mediated Knockdown
Knockdown of C/EBPb was performed essentially as described previously
(Siersbæk et al., 2011). Briefly, 3T3-L1 cells were transduced with pSicoR
PGK puro (12084; Addgene) lentivirus expressing shRNA against C/EBPb or
shRNA with a scrambled sequence at 70% confluency in growth media
supplemented with 8 mg/ml polybrene. Cells were then grown to confluence
and induced to differentiate 2 days after reaching confluence as described
above. MED1 ChIP-seq was performed for two independent biological
replicates.
ChIP-Seq
ChIP was performed essentially as described previously (Siersbæk et al.,
2012a). The following antibodies were used for immunoprecipitation: VDR
(C-20, sc-1008; Santa Cruz), KLF4 (GKLF, H-180, sc-20691; Santa
Cruz), c-Jun (H-79, sc-1694; Santa Cruz), PBX1 (Cat. No. 4342; Cell
Signaling), KLF5 (a kind gift from Dr. Huck-Hui Ng), STAT1 (E-23,
sc-346; Santa Cruz), JunB (210, sc-73; Santa Cruz), ATF2 (N-96, sc-6233;
Santa Cruz), ATF7 (S-15, sc-19764; Santa Cruz), FOSL2 (L-15, sc-171;
Santa Cruz), RXR (DN-197, sc-774; Santa Cruz), p300 (N-15, sc-584; Santa
Cruz), MED1 (M-255, sc-8998; Santa Cruz), BRG1 (2822-1; Epitomics),
H3K27ac (ab4729; Abcam), H3K4me1 (ab8895; Abcam), and H3K4me2
(9726; Cell Signaling). ChIP for all transcription factors and BRG1
was performed on formaldehyde crosslinked chromatin, and two

biological experiments were pooled. ChIP on H3K27ac, H3K4me1, and
H3K4me2 was performed on two biological replicates of formaldehyde
crosslinked chromatin and sequenced independently. ChIP for p300
and MED1 was performed once on chromatin that had been crosslinked
in 2 mM disuccinimidyl glutarate (DSG) for 45 min and subsequently
crosslinked by formaldehyde for 10 min. Chromatin-immunoprecipitated
DNA was subjected to deep sequencing on the Illumina platform according
to the instructions from the manufacturer (Nielsen and Mandrup, 2014).
ChIP-seq data for C/EBPb, C/EBPd, GR, STAT5A, and input control were
obtained from Siersbæk et al. (2011) and PPARg ChIP-seq data were obtained from Haakonsson et al. (2013).
4sU-RNA-Seq
4sU-RNA-seq was performed essentially as described previously (Rabani
et al., 2011). Briefly, cells were incubated with 400 mM 4sU for 30 min and
then harvested in TRIzol (Invitrogen). RNA was then purified according to
the manufacturer’s instructions. Purified RNA was biotinylated and pulled
down using streptavidin beads. Enriched RNA was then purified and subjected to standard mRNA sample preparation for sequencing, and
sequenced on the Illumina platform according to the manufacturer’s
instructions.
Alignment, Peak Calling, and Gene Regulation Analyses
Sequence tags were aligned to the genome (mm9) using Bowtie (Langmead
et al., 2009). ChIP-seq peaks were called using HOMER (Heinz et al., 2010),
and regulated genes were identified using the DESeq package in R (Anders
and Huber, 2010). Intersections between genomic position files were generated using BEDTools (Quinlan and Hall, 2010).
CoIP
Nuclei were isolated 4 hr after induction of 3T3-L1 differentiation and lysed
by low-grade sonication. Nuclear extract was obtained by centrifugation
(20,000 3 g, 30 min, 4 C). Cleared nuclear extract was subjected to coIPs
overnight at 4 C using C/EBPb (sc-150 AC; Santa Cruz) or IgG control
(sc-2345 AC; Santa Cruz) antibodies conjugated to agarose beads. After
extensive washing, immunoprecipitates were eluted by boiling in SDS buffer
and subsequently analyzed by MS/MS.
Nano-High-Performance Liquid Chromatography MS/MS Analysis of
Immunoprecipitates
CoIP samples were subjected to in-gel digestion with trypsin and subsequently analyzed using an EasyLC nanoLC (Proxeon) coupled with an LTQOrbitrap XL mass spectrometer (Thermo Fisher Scientific). MS/MS spectra
were processed and analyzed by using Proteome Discoverer (v1.4.0.288;
Thermo Fisher Scientific).
Additional information regarding the materials and methods used in this
work is available in Supplemental Experimental Procedures.
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Supplemental Figure Legends
Figure S1. Identification of 292 C/EBPβ-associated proteins by mass-spectrometry based proteomics
(Related to Figure 2). A) Western blot showing robust pull down of C/EBPβ specifically in the C/EBPβ
immunoprecipitation and not in the control experiment using an IgG control antibody. B) Venn diagram
showing overlap between the sets of proteins identified in two biological replicates of mass spectrometry
analyses of C/EBPβ-associated proteins (top). Quantification results of the identified proteins are shown at
the bottom.
Figure S2. Extensive co-localization of transcription factors at hotspots (Related to Figure 3). A) Fraction of
binding sites for the factors on the y-axis overlapping with binding of the factors on the x-axis in hotspot
regions. B,C) Re-ChIP results for ATF7-JunB, KLF5-KLF4, and KLF5-C/EBPβ as in Figure 3D. Results are
representative of two independent experiments. Screen shots for the three hotspots and control regions
are shown in panels D and E. D) Screen shots from the UCSC genome browser (http://genome.ucsc.edu)
(Kent et al., 2002) showing DHS-seq (Siersbæk et al., 2014, this issue of Cell Reports) and ChIP-seq data at
hotspots used for the re-ChIP experiments shown in Figure 3D and in panels B and C of this figure. E) Screen
shots from the UCSC genome browser showing ChIP-seq data for the binding regions used as control
regions in Figure 3D and panels B and C of this figure.
Figure S3. Hotspos are key regulators of gene activation (Related to Figure 4). A,B) Number of DHS-seq
(Siersbæk et al. 2014, this issue of Cell Reports) (A) and input control (Siersbæk et al., 2011) (B) sequence
tags at the regions defined in Figure 4C. C) Scatterplot showing the number of exon reads per kilobase
(RPK) for the two 4sU-RNA-seq replicates generated in preadipocytes before induction of differentiation
(day 0) and four hours after induction of differentiation. The R2 values are shown in each plot. D)
Enrichment of different types of transcription factor binding sites in the vicinity of all regulated genes as
defined in Figure 4D. Enrichment was determined as in Figure 4E. E) Enrichment of binding regions

occupied by 1 through 15 factors within 50 kb of the top 500 regulated genes. Enrichment was determined
as in Figure 4E.
Figure S4. Super-enhancers are large genomic regions associated with gene activation (Related to Figure 5
and 6). A) p300 signal at the merged transcription factor binding sites ranked by MED1 as in Figure 5A. B)
Size of super-enhancers and regular transcription factor binding regions outside super-enhancers. C) The
fraction of constituents in normal transcription factor binding regions and super-enhancers occupied by 1
through 15 factors that become occupied by PPARγ in mature adipocytes. PPARγ ChIP-seq data was
obtained from Haakonsson et al., 2013. D) Boxplots show the binding intensity (i.e. number of ChIP-seq
reads) at constituents in normal transcription factor binding regions and super-enhancers that are occupied
by each factor. E) mRNA expression during the first four hours of differentiation shown as exon reads per
kilobase (RPK) for genes associated with super-enhancers and for those associated with regular
transcription factor binding regions outside super-enhancers. Transcription factor binding regions were
assigned to the nearest gene in these analyses. F) Significantly enriched biological terms found to be
associated with super-enhancers. The super-enhancer associated genes were analyzed using DAVID (Huang
et al., 2009a, b) to identify significantly enriched terms. G) Western blot showing C/EBPβ protein levels in
3T3-L1 cells transduced with lentivirus expressing scrambled shRNA (shScr) or shRNA targeting C/EBPβ
(shC/EBPβ) after four hours of differentiation. TFIIB is shown as a loading control.

Tables S1 and S2
Data is supplied as separate excel-files. Both tables relate to Figure 2.
Table S1. List of C/EBPβ-associated proteins identified by mass spectrometry-based analyses (first
replicate). Co-immunoprecipitation (co-IP) was performed on nuclear extract from 3T3-L1 cells induced to
differentiate for four hours using antibodies against C/EBPβ (sample) and IgG (control). Proteins specifically
pulled down in the C/EBPβ IP were identified by mass spectrometry. The table shows the number of
identified peptides and the ratio between the signal in the C/EBPβ IP and the signal in the IgG control IP.
Table S2. List of C/EBPβ-associated proteins identified by mass spectrometry-based analyses (second
replicate). Data were generated as in Table S1 on a second independent biological replicate.

Supplemental Experimental Procedures
Alignment and analyses of ChIP-seq data
Sequence tags for ChIP-seq experiments were aligned to the mouse genome (mm9) using Bowtie
(Langmead et al., 2009) with the following options: --best --strata -m 3. Reads that align to the exact same
location in the genome were discarded. Aligned reads were analyzed by HOMER (Heinz et al., 2010) to
identify peaks of tag enrichment. Peaks were called for each transcription factor if they were four times
enriched relative to the local background (20 kb around the peak), four times enriched relative to a 3T3-L1
input control sample, and significant at a false discovery rate of 0.01%. A master set of peaks containing all
the identified peaks for all factors (if the center of two or more peaks were within 200 bp, the peaks were
merged) was defined. All peaks from this master set containing at least 20 tags per 10M tags in a 250 bp
window around the center of each peak for a given transcription factor were called as high-confidence
transcription factor binding sites. HOMER was also used for counting tags at the identified binding sites,
generating matrices for heat maps, and generating average tag counts. BEDTools (Quinlan and Hall, 2010)
was used to analyze position information for ChIP-seq peaks (e.g. intersection of peak files).
Alignment and analyses of 4sU-RNA-seq data
Reads from 4sU-RNA were aligned to the genome using an approach similar to that described previously
(Habegger et al., 2011). Briefly, tags were aligned to the mm9 genome and to a pseudo genome containing
all possible exon-exon junctions for all genes using Bowtie (Langmead et al., 2009) with the following
options: --best --strata –m 1. Mapped tags were subsequently combined. Tags within exons were
determined using HOMER (Heinz et al., 2010), and the tag counts were then analyzed using the DESeq
package in R (Anders and Huber, 2010). Significantly regulated genes were called using an adjusted P-value
of 0.01.

Nuclear extract
3T3-L1 fibroblasts were differentiated for four hours by stimulation with 3-isobutyl-1-methylxanthine,
dexamethasone, and insulin as described previously (Helledie et al., 2002). Approximately 108 cells were
used for nuclei isolation. After rinsing twice with cold PBS, cells were scrapped off the dish in cold PBS
containing protease inhibitors (Complete, EDTA-free Protease Inhibitor cocktail tablets, Roche Applied
Science (#05056489001)) and phosphatase inhibitors (1 mM sodium ortho-vanadate (NaOVan), 10 mM
NaF, 10 mM β-glycerol-phosphate) on ice. After centrifugation at 1,200xg for 5 min at 4 ⁰C, the pellet was
washed rapidly using 5X column volumes (CV) cold buffer A containing protease and phosphatase inhibitors
(PIs) (20 mM Tris-HCl pH=7.5, 20 mM NaCl, 0.2 mM EDTA pH 8.0, PIs) and the supernatant was removed.
The cell pellet was then resuspended in 5XCV of cold buffer A+PIs and kept on ice for 10 min in order to
swell. After 10 min, 1 volume of cold buffer A+NP-40+PIs (20 mM Tris-HCl pH=7.5, 20 mM NaCl, 0.2 mM
EDTA pH 8.0, 0.04% NP40, PIs) was added to the cell suspension, mixed gently and kept on ice for 10 min.
Nuclei were spun down at 1,200xg for 7 min at 4 ⁰C and the supernatant (cytosolic and cell membrane
proteins and particles) was removed. The nuclear pellet was washed twice with 5XCV of cold buffer A+PIs,
and the supernatant was removed each time after 5 min centrifugation at 4 ⁰C. The nuclear pellet was then
resuspended in 3XCV of cold buffer B+NP-40+PIs (20 mM Tris-HCl pH=7.5, 150 mM NaCl, 0.2 mM EDTA pH
8.0, 1% NP40, PIs) and kept on ice for 10 min. The nuclei were lysed by 6 cycles of sonication at low
intensity using a Bioruptor (Diagenode). Cleared nuclear extract was obtained by 30 min centrifugation at
20,000xg, 4 ⁰C. The cleared nuclear extract was divided into two equal amounts for immunoprecipitation
(before division a part of nuclei extract was taken out and saved as input for further investigation by
western blotting).
Co-Immunoprecipitation
Co-immunoprecipitation (Co-IP) was performed at 4 ⁰C unless otherwise indicated, using C/EBPβ antibody
conjugated to protein A/G agarose beads (sc-150 AC, Santa Cruz) in parallel with IgG antibody conjugated
to protein A/G agarose beads (sc-2345 AC, Santa Cruz). The antibody-conjugated beads were incubated

with nuclear extract overnight at 4 ⁰C on a rotator. Beads were washed three times in cold buffer B+1% NP40+PIs and subsequently three times with cold buffer B+PIs without NP-40 (20 mM Tris-HCl pH=7.5, 150
mM NaCl, 0.2 mM EDTA pH 8.0). The immunoprecipitates were eluted with 150 ul of elution buffer (50 mM
Tris-HCl pH=6.8, 2% SDS (BDH grade), 8% Glycerol, 0.008% bromophenol blue) at 100 ⁰C for 5 min. Eluates
were concentrated to 60 μl using vivaspin centrifugal concentrators 500 (VS0191) (10 ul of the original
samples were saved for the further investigation by western blotting).
SDS-PAGE and in-gel digestion
Samples were run on a 4-12% Bis-Tris gel (NuPage) according to the manufacturer’s instructions. The
proteins were visualized with coomassie staining and the gel background was destained with water. The
entire gel was diced into small pieces (1–2 mm), the gel pieces were then washed with water, and shrunk in
acetonitrile. The gel pieces were subjected to in-gel proteins reduction and alkylation with 10 mM DTT and
20 mM iodoacetamide, respectively. After sequential washing and dehydration with water and 50% ACN,
gel pieces were dried and rehydrated with 12.5 ng/μl trypsin solution in 50 mM ammonium bicarbonate on
ice for 45 min. The digestion was continued at 37 ⁰C overnight. The tryptic peptides were extracted with 5%
formic acid/50% acetonitrile and concentrated with vacuum centrifugation (Anal. Chem. 1996, 68, 850858). Samples were resuspended in 0.1% formic acid (solvent A).
Nano-HPLC MS/MS Analysis
Nano-LC-ESI-MS/MS was performed on an LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific,
Bremen, Germany) equipped with an EasyLC nanoLC (Proxeon, Odense, Denmark). The mobile phases
consisted of 0.1% formic acid (solvent A) and 0.1% formic acid in 95% ACN (solvent B). Peptides were
loaded onto a 20x0.1 mm trap column and separated by a 17 cm 75 µm ID picofrit column, both in-house
packed with C18 resin (Reprosil-Pur C18-AQ 3 µm; Dr. Maisch GmbH, Germany). Flowrate of the analysis
was 300 nL/min; with a linear gradient of solvent B from 5 to 35% over 45 min or 60 min. Spray voltage was
2.2 kV in positive-ion mode. Full scan spectra from m/z 300 to 1700 at resolution of 60,000 were acquired

in the orbitrap. The top seven most intense ions were selected each cycle for MS/MS fragmentation in the
LTQ-XL ion trap using CID with normalized collision energy of 35. Dynamic exclusion was used with the
following parameters: exclusion time 60 s, repeat count 1, repeat duration 1 s, exclusion mass width 10
ppm, and exclusion size 500. Singly charged species were excluded from MS/MS selection.
The acquired MS/MS spectra were analyzed with Proteome Discoverer (v1.4.0.288, Thermo Fisher
Scientific). Mascot (v2.3.2, Matrix Science, London, UK) was chosen as search engine, and data were
searched against the mouse Uniprot database (updated January 2013). Trypsin was selected as enzyme
with two missed cleavage allowed. Precursor mass tolerance was 8 ppm, product mass tolerance was 0.6
Da. Fixed modification was carbamidomethyl (C). Dynamic modifications were: oxidation (M), deamidation
(NQ) and acetylation (protein N-terminal). Results were filtered at a 5% false discovery rate (FDR), Mascot
score 20, and peptide rank 1. Label-free quantification was included in the workflow by adding the node
Precursor Area Detector in Proteome Discoverer, where chromatographic peak areas were integrated with
a tolerance of 2 ppm. Statistics was performed for both biological experiments to obtain the relative
enrichment values of quantified proteins in the C/EBPβ pull down sample compared to the control IgG pull
down.
Western Blotting
Nuclear extract input and the C/EBPβ and IgG co-IP samples or whole cell extracts from 3T3-L1 cells
transduced with lentivirus expressing scrambled shRNA or shRNA against C/EBPβ were submitted to SDSPAGE and separated proteins were subsequently blotted onto a PVDF membrane. After blocking in milk,
the membrane was then incubated with a primary antibody against C/EBPβ (sc-150, Santa Cruz) or TFIIB
(sc-225, Santa Cruz) followed by an anti-rabbit peroxidase-conjugated secondary antibody (Dako) and
developed by enhanced chemiluminescence (ECL).

Sequential ChIP (Re-ChIP)
Cross-linked chromatin from 3T3-L1 cells differentiated for four hours was immunoprecipitated with
antibody against the first factor of interest as described in the main paper except that chromatin was
eluted in a solution of 10 mM DTT and 1% SDS gently rotating for 30 minutes at room temperature. Eluted
chromatin was diluted 20-fold, divided into two equal amounts, and subjected to the second
immunoprecipitation with antibody against the second factor of interest as well as an IgG control. The
second elution was done using a standard elution buffer (1% SDS, 0.1 M NaHCO3 gently rotating for 30
minutes at room temperature). The isolated chromatin was decross-linked, purified by phenol-chloroform
extraction, and analyzed using qPCR. Primers are available upon request.
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